Alk-positive Anaplastic Large Cell Lymphoma

• CLINICAL_TRIALS trial_result · 2021-03-15
  Clinical Trial Update: Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL [Phase 1, Phase 2]

  Phase 1/2 trial evaluating tislelizumab plus lenalidomide in refractory/relapsed elderly patients with various aggressive B-cell lymphomas, …

• CLINICAL_TRIALS trial_result · 2018-10-16
  Clinical Trial Update: Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL [Phase 4]

  Phase 4 trial evaluating crizotinib with etoposide capsule followed by autologous HSCT for relapsed and refractory ALK-positive anaplastic l…